Sponsoring partners
Companies choose to partner with VILDA to champion diversity, enhance company health, and empower women in leadership. Below are the companies who are currently sponsoring the network to shape a thriving, inclusive life sciences industry, while showcasing their commitment to meaningful change.
Relevans is a full-service agency with more than 21 years of experience in health-related communication. Most of our clients are active in life science, and we work with everything from prescription drugs to disease awareness in public channels. Here you will find experienced creatives as well as IMA-certified project and production managers. This allows us to always adapt tonality, visual expression, and channel according to the recipient.
Cytel offers experts within all aspects of drug development. Cytel will get you there, strategically and operationally, including regulatory guidance, clinical trial design, RWE, sponsor oversight, toxicology, DMPK, industry-leading statistical software, advanced analytics and more. Drug development with flexibility, teamwork, and the smartest endpoints; by Cytel.
Do you want to know more? Visit our website www.cytel.com or meet us at Sankt Eriksgatan 113, Stockholm.
Cytel has been sponsoring VILDA since the start in May 2023. The sponsorship includes support from Micaela Lampe managing VILDA administration.
Event partners
VILDA collaborates with companies to organize events that aim to bring value to VILDA members. Below are the companies who have helped VILDA organize network meetings and other activities.
Redeye
Redeye is the next generation equity research and investment banking company, specialized in Life Science and Technology.
Linc
Linc invests in product oriented companies in the Nordic Life Science industry – primarily in pharmaceutical and medical technology companies.
Want to be part of our network?
All women in leadership positions from the life science industry can become members in VILDA.
If this is not you, we always welcome your involvement as a sponsor.